Oxford Nanopore Technologies

(ONT)
Sector: Pharmaceuticals & Biotechnology
133.60p
4.80p 3.73
Last updated: 09:17:03

1 day chart

6 month chart

DIY Investing
Hargreaves Lansdown - Improve the way you pick shares

Today's buy and sell prices

The price at which you can buy a share or investment. It is usually higher than the bid (sell) price. It’s the price you are being offered. Offer 133.80p
The price at which you can sell a share or investment. It is lower than the offer (buy) price. Bid 133.30p
The difference between the bid and offer prices expressed as a percentage. When you buy shares you pay a higher price than you get when you sell them. The difference between these prices is the profit made by the market maker who puts the deals together. Spread 0.37

Today's trading

Range The lowest and the highest price a share has reached in the trading day. 127.80p-133.60p
The lowest and the highest price a share has reached in the trading day. Volume 157,791.00
The lowest and the highest price a share has reached in the trading day. Today's open 127.80p
At the end of the trading day there is an official closing price for every share. The previous session’s close is used as the base to calculate the following day’s price changes. Previous close 122.80p

Yearly summary

The highest and lowest prices the shares have traded at over a rolling 52-week period. It gives you a good indication of how the share price is performing now relative to its recent past performance. 52wk range 86.55p-208.20p

Fundamentals and health

A measure of the company's worth on the stock market. We display the previous closing share price multiplied by the number of shares in issue. Market capitalisation £1,274.69
The number of shares a company has in circulation, in millions. Shares in issue 862.82
The main valuation used by investors and a way of gauging whether a company's share price is cheap or expensive compared to competitors. You get PE by dividing the share price by the earnings per share (EPS). Our figure is last basic unadjusted - reported - annual EPS / current share price x 100. Companies also quote adjusted EPS figures to remove the effect of one-off exceptional figures from the profit figures. There is debate among investors as to whether this should be used. We use basic EPS – the purest figure. PE ratio n/a
PEG ratio n/a
An important ratio for showing how much profit after tax and other deductions (net profit) is actually being earned per share. You divide the net profit by the number of shares in issue. Expressed in pence per share. Looking at whether the EPS is rising or falling over time is one of the most important indicators of whether a company is really making money for its shareholders. Our figure is undiluted, meaning it is not adjusted for exceptional costs. EPS -19.00p
Earnings per share growth illustrates the growth of earning per share over the last two reporting periods. It helps investors identify stocks that are increasing or decreasing in profitability. A minus sign indicates negative growth. EPS growth n/a
Return on capital employed measures a company's profitability in relation to how much capital is invested in the business. Generally, the higher the figure the better but with all these ratios it is best to compare companies from the same sector. A high double digit figure may mean a company has an advantage over its competitors because of a unique product but an oil company, for example, will have higher capital outlay than an online retailer. Our formula: [Pre-tax profit / (total assets – short-term liabilities)] * 100 ROCE -25.25
Also known as the acid test ratio, it's a quick guide to how well a company can pay its short-term debts. Above 1 is considered healthy. A ratio of 1.5 would mean the company has £1.50 of liquid (accessible) assets to cover each £1 of debt (current liabilities). Formula: Current assets minus inventory / current liabilities. Quick ratio 3.87
Indicates whether a company can convert assets into cash to pay its debts within the next 12 months. It is calculated as current assets / current liabilities for the same period but will display as '0' for companies such as banks that don't distinguish between short and long-term liabilities. Current ratio 5.01
The amount of money a company paid to a shareholder for each share they own over the past 12 months, expressed in pence. Total dividends per share n/a
The dividends paid per share over the past 12 months (interim plus final) as a percentage of the share price. Our figure includes recurring special dividends. Dividend yield n/a
The number of times the dividend could have been paid out from net profits. It is a good indicator of the company's ability to pay the dividend and its level of generosity. Formula: earnings per share / dividends per share. More than 2 is considered healthy, less than 1.5 may hint that a dividend is at risk of being cut. Dividend cover n/a
Dividend per share growth n/a

Oxford Nanopore Technologies Fundamentals

The Group was founded in 2005 as a spin-out from the University of Oxford by Gordon Sanghera,Spike Willcocks and Professor Hagan Bayley (currently Professor of Chemical Biology at the Universityof Oxford). During the early years of the Company, the Group formed collaborations with key academicscientists in the field of nanopore sensing, including Professor Dan Branton at Harvard University, andProfessors David Deamer and Mark Akeson at the University of California (Santa Cruz). The collaborationsincluded sponsorship of fundamental research in these labs and the formation of patent licensingagreements with these and other institutions to form a foundational portfolio of nanopore sensing expertiseand IP.

Oxford Nanopore Technologies Latest trades

Latest trades

Date Time Price Amount Value Type Buy / sell
25/11/2024 09:11:02 133p 31 £41.23 AT Sell
25/11/2024 09:06:00 133p 944 £1,255.52 AT Buy
25/11/2024 09:03:04 133p 1,346 £1,790.18 AT Buy
25/11/2024 09:02:00 133p 1,195 £1,589.35 O Buy
25/11/2024 09:00:05 133p 3,764 £5,006.12 O Buy

Analysis

Buy Sell Unknown
Quantity 56 32 8
Volume 117,388 44,113 24
Value £155,039 £58,166 £31

Oxford Nanopore Technologies Director dealings

Trade date Director Volume / Price Trade value Trade type
12/11/2024 Nick Keher 105 @ 0.00 0.00 Transfer From
12/11/2024 Nick Keher 105 @ 142.00p £149.10 Buy
15/10/2024 Gurdial (Gordon) Sanghera 1,993,571 @ 141.66p £2,824,092.68 Sell
14/10/2024 Gurdial (Gordon) Sanghera 4,231,034 @ 0.00 0.00 Transfer From
11/10/2024 Nick Keher 99 @ 0.00 0.00 Transfer From
11/10/2024 Nick Keher 99 @ 152.00p £150.48 Buy
12/09/2024 Nick Keher 102 @ 0.00 0.00 Transfer From
12/09/2024 Nick Keher 102 @ 146.00p £148.92 Buy
13/08/2024 Nick Keher 122 @ 0.00 0.00 Transfer From
13/08/2024 Nick Keher 122 @ 122.00p £148.84 Buy

Oxford Nanopore Technologies Broker views

Date Broker Recomm. Old target price New target price Notes
04/09/2024 Deutsche buy - 190.00p reiteration
03/09/2024 Berenberg Bank buy - 282.00p reiteration
03/07/2024 Berenberg Bank buy 350.00p 282.00p reiteration
28/06/2024 RBC Capital Markets outperform - 260.00p reiteration
23/05/2024 JP Morgan Cazenove overweight - - reiteration
17/04/2024 Berenberg Bank buy - 350.00p reiteration
12/04/2024 Citigroup buy - 210.00p reiteration
16/11/2023 JP Morgan Cazenove overweight - - reiteration
13/11/2023 RBC Capital Markets outperform 350.00p 300.00p reiteration
07/09/2023 Barclays overweight - 355.00p reiteration
Stockopedia: Comprehensive stock market insights